Medicinal Organic Cannabis Australia (MOCA) is the first organic cannabis company in Australia commencing in 2017.
They are focused on reducing patient access costs in Australia, where locally produced products and imported products can cost as much as AUD$1200 per month. MOCA anticipates its product range will be on the market for around AUD$100 for a 50 gram container. Well below current product prices.
“With the high levels of stress and anxiety occurring around the world as a result of Covid19, it's very important that patients in need can access medical cannabis without affordability being an issue”, said Sorbello. He went on to say that his team at MOCA believe that the 21st century is about producing affordable organic plant based medicine”.
Currently, in Australia many patients are excluded from accessing medical cannabis due to high costs and lack of government subsidies. The Company has entered into the CBD Horse Pellets market in Europe in 2020.
Invest in Marijuana
Welcome to InvestInMarijuana.com.au, internationally cannabis has hit the headlines in a major fashion over the past few years and it is due to relatively unknown recent scientific discoveries which have the potential to revolutionize health care worldwide for humans and for their pets. This key discovery is that humans have an Endocannabinoid System (ECS) which responds to cannabis and the ECS is responsible for maintaining good health. Research is indicating that the cannabinoids found in cannabis may one day soon be more prevalent that vitamin C and will be in all forms of products ranging from foods to cosmetics.
We invite you to buy shares in OrganicMarijuana.com - be part of our growth in organic cultivation in southern Europe as we build the largest greenhouse network.
Invest In Marijuana Industry in Australia and New Zealand
Investing in Cannabis in Australia with MOCA offers the opportunity to be at the forefront of this global industry. MOCA is an Australian Cannabis Wholesaler Company which holds licences at a State and Federal level in Australia under the Australian Government’s new medical cannabis regulatory system and is currently seeking licences from the government to undertake research, importation, production and to cultivate cannabis for human medicinal purposes in New Zealand.
Marijuana Investment Opportunities in Australia
In October 2016, the Australian government legislated to make provisions for the legal cultivation of medicinal cannabis. With this change in legislation, Australia entered into the global marketplace alongside countries such as Italy, Israel, Canada, United States and many others which have legislated to make available medicinal cannabis.
Research indicates that the cannabis products have beneficial properties for a series of medical conditions and symptoms including pain, epilepsy, and a number of other clinical conditions. With the birth of this industry, in Australia, opportunities abound investment to produce organic clinically proven medical cannabis. Medicinal Organic Cannabis Australia (MOCA) is positioning to become a producer, cultivator and promoter of the Marijuana industry in Australia and internationally.
The key strengths of the company are its powerful internet presence – the long vision of its founders on promoting the products in an industry where the race is to become cultivators of the plant. On that subject, MOCA has embraced an innovative and eco-friendly strategy to cultivate medical and recreational cannabis both for an Australian and international market.
In addition, the prescription opioid epidemic sweeping the world sees an estimated 26-36 million people abusing prescription opioids. Research reveals that cannabis is helping patients deal with ailments without the addictive aspects of opioids. This massive surge in demand for cannabis based products indicates that the market may become a US$500 billion industry and in the short term will reach US$146.4 billion by end of 2025.
Medicinal Organic Cannabis Australia (MOCA) entered this market in 2017 with the view to become a global leader in the production and distribution of medical cannabis products and since that time has worked to position itself as an industry leader. The company has obtained Australian importation and exportation licences and has partnered with industry leaders to provide premium organic cannabis. based medication.
Latest Scientific Research Debunks Claims That Cannabis Harms Brain
Claims that cannabis use is linked to or is the cause of lower cognitive functions are largely based upon the findings of a single longitudinal study. The paper, published by researcher Madeline Meier of Duke University and her team in 2012, reported that the onset of cannabis use in early adolescence was associated with an average decline of eight IQ points by middle-age.
However, scientific journal Proceedings of the National Academy of Science published a critique of Meier’s study, indicating that the reported differences in IQ were consistent with socioeconomic differences among the study’s participants and were not attributable to cannabis. Read More
Marijuana is so much more than just THC - a pharmacologist looks at the unexploited healing compounds of the plant
MOCA is seeking to raise investment to build and develop various aspects of its commercial enterprise including construction of a pharmaceutical grade cultivation and extraction facility.
MOCA’s points of differentiation include the use of indoor cultivation in controlled environments, utilising aquaponic systems designed to create medicinal organic cannabis products for local and international market supply.
Key to MOCA's points of differentiation is the agreement with New Realm to leverage its strategic digital platform to market organic products in Australia, New Zealand and internationally.
As of November 2018, medicinal cannabis is legal in 33 states in USA. Yet the federal government still insists on claiming that marijuana has no legal use and is easy to abuse. In the meantime, medicinal marijuana dispensaries have an increasing array of products available for anxiety, pain, sex and more.
Marijuana dispensaries are full of glass jars of products and many strains for sale have evocative and magical names like Blue Dream, Bubba Kush and Chocolope. But what does it all mean? Are there really differences in the medical qualities of the various strains?
James David Adams, Associate Professor of Pharmacology and Pharmaceutical Sciences at the University of Southern California looks into the medical properties of marijuana. Read More
Medicinal Organic Cannabis Australia (MOCA) is a fully licenced medical cannabis company specialized in importation and exportation of organic cannabinoids for Australian and New Zealand Markets. MOCA has strategic International partnerships which offer a proven, sustainable, stream of high quality products. We are supported by leading web based marketing platform to bring our products to Australian and international markets.
Cannabis Prescription is an online service that offers patients access to medical doctors in Australia, specialized in medical cannabis. Currently working with MOCA, for medicinal cannabis medication. MOCA is a fully licenced medical cannabis company based with its headquarters in Sydney Australia and offices in New Zealand. The company imports a range of cannabidiol (CBD) products and THC rich medications.
Invest In Cannabis is an online portal into the Australian and New Zealand cannabis industry. Today cannabis is considered one of the leading emerging medications which hold high promise for good health and healing.
The company has made strategic partnerships which enable MOCA to leverage dozens of other premium digital assets to sell to an international audience. It now seeks a suitable logistics partner with significant scalability properties to assist with its objectives of supporting cultivation and distribution.
Much news and discussion has evolved in recent decades regarding the role of marijuana in both the medical and recreational market. Medical marijuana has featured strongly as an alternative source of natural well-being around the world with nations such as Canada, Israel and Uruguay opening up to medicinal cannabis industries. International growth and interest in the marijuana industry has been nothing short of spectacular over the past couple of years with the legal cannabis market estimated to reach $50 billion in the U.S. alone by 2026.